Cyfuse Biomedical K.K. (TYO:4892)

Japan flag Japan · Delayed Price · Currency is JPY
711.00
+1.00 (0.14%)
Apr 28, 2026, 3:30 PM JST
-27.60%
Market Cap 7.08B
Revenue (ttm) 230.00M
Net Income (ttm) -763.00M
Shares Out 9.96M
EPS (ttm) -86.69
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 57,000
Average Volume 174,220
Open 702.00
Previous Close 710.00
Day's Range 694.00 - 711.00
52-Week Range 516.00 - 1,068.00
Beta 1.41
RSI 61.33
Earnings Date May 14, 2026

About Cyfuse Biomedical K.K.

Cyfuse Biomedical K.K. develops, manufactures, and sells regenerative medicine-related products in Japan, Europe, and the United States. The company offers the Bio 3D Printer for use in the regeneration of various tissues and organs, such as cartilage and bone, blood vessels, and nerves; regenova, a 3D software that creates 3D data where spheroids shall be mounted; and S-PIKE that develops 3D-structures from cells. It also provides the Human 3D Mini-Liver, an in vitro MASH model that recapitulates human liver functions and predicts efficacy of ... [Read more]

Sector Healthcare
Founded 2010
Employees 23
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4892
Full Company Profile

Financial Performance

In 2025, Cyfuse Biomedical K.K.'s revenue was 230.00 million, an increase of 325.93% compared to the previous year's 54.00 million. Losses were -763.00 million, -12.50% less than in 2024.

Financial Statements

News

There is no news available yet.